Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Niklas Mattsson

Showing results (21-30 of 395) with videos related to

Pageof 40
Sort By:
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 8, 2015
Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal EldersTimothy C Durazzo, Niklas Mattsson, Michael W Weiner, et al.
Lakartidningen|November 25, 2011
[Automated cerebrospinal fluid cell count. A valuable contribution to diagnostics of brain diseases]Mariann Wall, Niklas Mattsson, Henrik Zetterberg, et al.
JAMA Neurology|March 28, 2017
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseNiklas Mattsson, Ulf Andreasson, Henrik Zetterberg, et al.
Alzheimer'S Research & Therapy|February 1, 2014
Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samplesTobias Skillbäck, Henrik Zetterberg, Kaj Blennow, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 21, 2017
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survivalTobias Skillbäck, Niklas Mattsson, Kaj Blennow, et al.
JAMA Neurology|October 12, 2020
Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive ImpairmentPhilip S Insel, Oskar Hansson, Niklas Mattsson-Carlgren
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2014
Smoking and increased Alzheimer's disease risk: a review of potential mechanismsTimothy C Durazzo, Niklas Mattsson, Michael W Weiner, et al.
Neurobiology of Disease|June 8, 2014
Bidirectional links between Alzheimer's disease and Niemann-Pick type C diseaseMartina Malnar, Silva Hecimovic, Niklas Mattsson, et al.
Biomarkers in Medicine|April 14, 2010
Biochemical markers in Alzheimer's disease clinical trialsHenrik Zetterberg, Niklas Mattsson, Les M Shaw, et al.
Nature Communications|January 5, 2021
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studiesNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kaj Blennow, et al.
Pageof 40

Showing results (21-30 of 395) with videos related to

Sort By:
Pageof 40
Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco|April 8, 2015
Interaction of Cigarette Smoking History With APOE Genotype and Age on Amyloid Level, Glucose Metabolism, and Neurocognition in Cognitively Normal EldersTimothy C Durazzo, Niklas Mattsson, Michael W Weiner, et al.
Lakartidningen|November 25, 2011
[Automated cerebrospinal fluid cell count. A valuable contribution to diagnostics of brain diseases]Mariann Wall, Niklas Mattsson, Henrik Zetterberg, et al.
JAMA Neurology|March 28, 2017
Association of Plasma Neurofilament Light With Neurodegeneration in Patients With Alzheimer DiseaseNiklas Mattsson, Ulf Andreasson, Henrik Zetterberg, et al.
Alzheimer'S Research & Therapy|February 1, 2014
Cerebrospinal fluid biomarkers for Alzheimer disease and subcortical axonal damage in 5,542 clinical samplesTobias Skillbäck, Henrik Zetterberg, Kaj Blennow, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|June 21, 2017
Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survivalTobias Skillbäck, Niklas Mattsson, Kaj Blennow, et al.
JAMA Neurology|October 12, 2020
Association Between Apolipoprotein E ε2 vs ε4, Age, and β-Amyloid in Adults Without Cognitive ImpairmentPhilip S Insel, Oskar Hansson, Niklas Mattsson-Carlgren
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 14, 2014
Smoking and increased Alzheimer's disease risk: a review of potential mechanismsTimothy C Durazzo, Niklas Mattsson, Michael W Weiner, et al.
Neurobiology of Disease|June 8, 2014
Bidirectional links between Alzheimer's disease and Niemann-Pick type C diseaseMartina Malnar, Silva Hecimovic, Niklas Mattsson, et al.
Biomarkers in Medicine|April 14, 2010
Biochemical markers in Alzheimer's disease clinical trialsHenrik Zetterberg, Niklas Mattsson, Les M Shaw, et al.
Nature Communications|January 5, 2021
Publisher Correction: Increasing the reproducibility of fluid biomarker studies in neurodegenerative studiesNiklas Mattsson-Carlgren, Sebastian Palmqvist, Kaj Blennow, et al.
Pageof 40